OlafStuveMDPhD(He/Him)

PubMed

• Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion.
  Afsaneh Shirani, Olaf Stuve, Anne H Cross> ;Neurologic Clinics. 2024 Feb 1
• Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design.
  Rehana Z Hussain, Mariam Madinawala, Julie Korich, Lori A Lebson, Amber Salter, Navid Manouchehri, Peter V Sguigna, Annette Okai, Kyle M Blackburn, Lauren Tardo, Jeffr...> ;Therapeutic Advances in Neurological Disorders. 2024 Jan 1
• Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.
  Anne H Cross, Afsaneh Shirani, Olaf Stuve> ;Therapeutic Advances in Neurological Disorders. 2024 Jan 1
• Perspective: Industry-patient relationships for the promotion of pharmaceutical agents.
  Meredith A Bryarly, Michael A Rubin, Olaf Stuve> ;Therapeutic Advances in Neurological Disorders. 2023 Jan 1
• Editorial: Animal models of multiple sclerosis: can they advance future therapies?
  Tara Maria DeSilva, Olaf Stuve> ;Frontiers in Molecular Neuroscience. 2023 Jan 1
• 1 citations
  Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis.
  Rebecca I Spain, Andrea Hildebrand, Carin S Waslo, William D Rooney, Joshua Emmons, Daniel L Schwartz, Mark S Freedman, M Mateo Paz Soldan, Pavle Repovic, Andrew J Sol...> ;Frontiers in Neurology. 2023 Jan 1
• 2 citations
  Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy.
  Doris Lambracht-Washington, Min Fu, Navid Manouchehri, Linda S Hynan, Olaf Stuve, Roger N Rosenberg> ;Aging Brain. 2023 Jan 1
• 3 citations
  Microglia as a cellular target of diclofenac therapy in Alzheimer's disease.
  Rick A Weideman, Danni McMahan, David A Jacob, Bertis B Little, Hsueh-Sheng Chiang, Nil Saez Calveras, Olaf Stuve, Stopschinski, B.> ;Therapeutic Advances in Neurological Disorders. 2023 Jan 1
• 5 citations
  T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
  Anthony T Reder, Olaf Stuve, Stephanie K Tankou, Thomas P Leist> ;Multiple Sclerosis. 2023 May 1
• 4 citations
  Tau seeding in cases of multiple sclerosis.
  Michael S LaCroix, Hilda Mirbaha, Ping Shang, Stephanie Zandee, Chan Foong, Alexandre Prat, Olaf Stuve, Marc I Diamond, White, C. L., Charles L White 3rd> ;Acta Neuropathologica Communications. 2022 Oct 11
• 2 citations
  Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.
  Hsueh-Sheng Chiang, Alka Khera, Olaf Stuve, John Hart Jr, Brendan Kelley, Trung Nguyen, Stopschinski, B.> ;Geriatrics. 2022 Jun 5
• 1 citations
  To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England.
  Bastian Tugemann, Navid Manouchehri, Olaf Stuve> ;Multiple Sclerosis and Related Disorders. 2022 Mar 1
• 2 citations
  The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review.
  Nil Saez-Calveras, Amy L Brewster, Olaf Stuve> ;Frontiers in Molecular Neuroscience. 2022 Jan 1
• 8 citations
  The role of the complement system in Multiple Sclerosis: A review.
  Nil Saez-Calveras, Olaf Stuve> ;Frontiers in Immunology. 2022 Jan 1
• The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives.
  Rehana Z Hussain, Peter V Sguigna, Annette Okai, Crystal Wright, Mariam Madinawala, Ann D Bass, Gary R Cutter, Navid Manouchehri, Olaf Stuve> ;Journal of Central Nervous System Disease. 2022 Jan 1
• Utilization of a neurology specialty service by primary care providers for headache management at a tertiary care hospital.
  Samra Vazirian, Travis Ho, Rick A Weideman, Meagen R Salinas, Paul W Hurd, Olaf Stuve> ;Journal of Central Nervous System Disease. 2022 Jan 1
• 2 citations
  Clinical trials in multiple sclerosis: past, present, and future.
  Navid Manouchehri, Afsaneh Shirani, Victor H Salinas, Lauren Tardo, Rehana Z Hussain, David Pitt, Olaf Stuve> ;Neurologia i Neurochirurgia Polska. 2022 Jan 1
• 9 citations
  Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure.
  Navid Manouchehri, Victor H Salinas, Negar Rabi Yeganeh, David Pitt, Rehana Z Hussain, Olaf Stuve> ;Frontiers in Neurology. 2022 Jan 1
• 12 citations
  Choroid plexus volumetrics and brain inflammation in multiple sclerosis.
  Navid Manouchehri, Olaf Stüve> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Oct 5
• 9 citations
  Apolipoprotein E receptor 2 deficiency decreases endothelial adhesion of monocytes and protects against autoimmune encephalomyelitis.
  Laurent Calvier, Navid Manouchehri, Anastasia Sacharidou, Chieko Mineo, Philip W. Shaul, David Y. Hui, Maria Z. Kounnas, Olaf Stüve, Joachim Herz> ;Science Immunology. 2021 Aug 27
• 26 citations
  Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database.
  Natalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, Olaf Stüve> ;Multiple Sclerosis. 2021 Jun 1
• 11 citations
  CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity
  Navid Manouchehri, Rehana Z. Hussain, Petra D. Cravens, Ekaterina Esaulova, Maxim N. Artyomov, Brian T. Edelson, Gregory F. Wu, Anne H. Cross, Richard Doelger, Nicolas...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Apr 6
• 9 citations
  Disease-modifying therapy prescription patterns in people with multiple sclerosis by age:
  Yinan Zhang, Amber Salter, Shan Jin, William J. Culpepper, Gary Cutter, Mitchell T. Wallin, Olaf Stüve> ;Therapeutic Advances in Neurological Disorders. 2021 Mar 31
• The antioxidant MnTBAP does not effectively downregulate CD4 expression in T cells in vivo
  Navid Manouchehri, Dikran R Guisso, Rehana Z. Hussain, Berge A. Minassian, Olaf Stüve> ;Journal of Neuroimmunology. 2021 Mar 8
• Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy.
  Navid Manouchehri, Lawrence Steinman, Olaf Stüve> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2021 Mar 1
• Join now to see all